Safety of physostigmine administration in patients presenting to the emergency department with anticholinergic poisoning
-
Report By: Guillaume Lacombe, MD - PGY-4, Emergency Medicine
-
Institution: Université Laval
-
Date Submitted: 15th July 2016
-
Last Modified: 21st July 2016
-
Status: Red (incomplete)
Three Part Question
In [patients presenting to the emergency department with anticholinergic toxidrome], is the administration of [physostigmine] associated with [major adverse events]?